TY  - CONF 
AU  - Emperiale, V.
AU  - Sanchez-Piedra, C.
AU  - Bohorquez, C.
AU  - Colazo, M.
AU  - Fernandez-Lopez, C.
AU  - Busquets, N.
AU  - Ros, I.
AU  - Blanco, J. M.
AU  - Moreno, M.
AU  - Esteban, J. C.
AU  - Rodriguez-Escalera, C.
AU  - Sanchez-Alonso, F.
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2019
SN  - 0003-4967
UR  - http://hdl.handle.net/20.500.11940/15627
AB  - Background The advent of biologic therapy (BT) in ankylosing spondylitis (AS) has substantially benefited patients with inadequate response to conventional therapy. However, it is known patients with inadequeate response to a 1st BT have worse...
TI  - Effectiveness of biologic therapy on disease activity in ankylosing spondylitis: a BIOBADASER III observational study
DO  - 10.1136/annrheumdis-2019-eular.214
KW  - CHUS
VL  - 78
ER  -